A commentary on the process of peer review and pathology data locking.
about
Recommendations for pathology peer review.Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findingsBest practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and biotechnology industries.Regulatory forum opinion piece*: pathology peer review--to lock or not to lock, is that really the question?
P2860
A commentary on the process of peer review and pathology data locking.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A commentary on the process of peer review and pathology data locking.
@ast
A commentary on the process of peer review and pathology data locking.
@en
A commentary on the process of peer review and pathology data locking.
@nl
type
label
A commentary on the process of peer review and pathology data locking.
@ast
A commentary on the process of peer review and pathology data locking.
@en
A commentary on the process of peer review and pathology data locking.
@nl
prefLabel
A commentary on the process of peer review and pathology data locking.
@ast
A commentary on the process of peer review and pathology data locking.
@en
A commentary on the process of peer review and pathology data locking.
@nl
P2093
P2860
P356
P1476
A commentary on the process of peer review and pathology data locking
@en
P2093
Brad Bolon
Erio Barale-Thomas
Frédéric Schorsch
Jennifer S McKay
Jerry Hardisty
Klaus Weber
Munehiro Teranishi
Sunao Manabe
P2860
P304
P356
10.1177/0192623310364024
P407
P577
2010-03-17T00:00:00Z